Optimising Renal Tumour Management Through Artificial Intelligence Modules

Recruiting Observational Study
Renal Neoplasms Pathology Renal Cell Cancer
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
2,100 (estimated)
Sponsor
Shao Pengfei · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to improve the management of people with renal tumour by multimodal artificial intelligence(AI). It will also measure the accuracy of the predictions from AI models. The main questions it aims to answer are: 1. whether the AI module can accurately provide tumor-related information such as Benign or malignant, subtypes, grading, stage, etc. by learning from …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with renal tumor which can be treated by surgery; * Complete CECT within 30 days before surgery; * Patients who fully understand this study and sign the informed consent; Exclusion Criteria: * Patients with any item missing from the baseline clinical and pathologica…
Contacts

Shao Pengfei, Professor

+8613851925825

spf032@hotmail.com

CONTACT

Miao Haoqi, Postgraduate

+8613276636957

mhq@stu.njmu.edu.cn

CONTACT